The US Food and Drug Administration (FDA) will replace animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods. The new approach is designed to improve drug safety and accelerate the evaluation process, while reducing animal experimentation, lowering research and development (R&D) costs, and ultimately, drug prices, according to FDA. The move does not impact testing requirements for all drugs, including sunscreens. ...